News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,070 Results
Type
Article (14382)
Company Profile (281)
Press Release (254407)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79671)
Career Advice (152)
Deals (13246)
Drug Delivery (35)
Drug Development (50650)
Employer Resources (31)
FDA (5779)
Job Trends (5144)
News (144922)
Policy (10245)
Tag
Academia (916)
Accelerated approval (2)
Adcomms (13)
Allergies (52)
Alliances (21728)
ALS (64)
Alzheimer's disease (912)
Antibody-drug conjugate (ADC) (100)
Approvals (5809)
Artificial intelligence (126)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4569)
BIOSECURE Act (6)
Biosimilars (44)
Biotechnology (232)
Bladder cancer (59)
Brain cancer (20)
Breast cancer (156)
Cancer (1490)
Cardiovascular disease (118)
Career advice (133)
Career pathing (2)
CAR-T (118)
Cell therapy (333)
Cervical cancer (8)
Clinical research (41218)
Collaboration (546)
Compensation (263)
Complete response letters (13)
COVID-19 (1038)
CRISPR (42)
C-suite (166)
Cystic fibrosis (76)
Data (1535)
Denatured (11)
Depression (31)
Diabetes (139)
Diagnostics (1310)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (29893)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48726)
Executive appointments (466)
FDA (6497)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (499)
Gene editing (97)
Generative AI (10)
Gene therapy (255)
GLP-1 (369)
Government (1126)
Grass and pollen (2)
Guidances (27)
Healthcare (6612)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (93)
Indications (20)
Infectious disease (1103)
Inflammatory bowel disease (115)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (17)
IPO (7280)
IRA (11)
Job creations (861)
Job search strategy (127)
Kidney cancer (7)
Labor market (5)
Layoffs (211)
Leadership (3)
Legal (1391)
Liver cancer (33)
Lung cancer (205)
Lymphoma (104)
Machine learning (3)
Management (7)
Manufacturing (141)
MASH (54)
Medical device (2637)
Medtech (2638)
Mergers & acquisitions (6299)
Metabolic disorders (391)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1324)
NextGen: Class of 2025 (2021)
Non-profit (858)
Now hiring (21)
Obesity (194)
Opinion (102)
Ovarian cancer (63)
Pain (44)
Pancreatic cancer (56)
Parkinson's disease (122)
Partnered (8)
Patents (130)
Patient recruitment (79)
Peanut (35)
People (25703)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14543)
Phase II (19171)
Phase III (12145)
Pipeline (821)
Policy (46)
Postmarket research (854)
Preclinical (6146)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (292)
Real estate (1423)
Recruiting (12)
Regulatory (8833)
Reports (15)
Research institute (943)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (61)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1976)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (9)
The Weekly (36)
Vaccines (216)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (1)
Last 7 days (521)
Last 30 days (1445)
Last 365 days (19513)
2025 (6379)
2024 (20626)
2023 (22478)
2022 (26882)
2021 (27859)
2020 (23412)
2019 (16271)
2018 (11795)
2017 (13786)
2016 (11881)
2015 (14389)
2014 (10426)
2013 (7513)
2012 (7566)
2011 (7657)
2010 (7448)
Location
Africa (149)
Alabama (42)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17410)
Australia (2940)
California (3895)
Canada (1146)
China (361)
Colorado (150)
Connecticut (152)
Delaware (103)
Europe (37337)
Florida (476)
Georgia (117)
Idaho (16)
Illinois (234)
India (10)
Indiana (92)
Iowa (2)
Japan (80)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (501)
Massachusetts (3102)
Michigan (70)
Minnesota (146)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (15)
New Jersey (972)
New Mexico (12)
New York (1052)
North Carolina (557)
North Dakota (5)
Northern California (1720)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (744)
Puerto Rico (6)
Rhode Island (19)
South America (209)
South Carolina (4)
Southern California (1499)
Tennessee (25)
Texas (450)
United States (13390)
Utah (53)
Virginia (80)
Washington D.C. (30)
Washington State (353)
Wisconsin (15)
269,070 Results for "cdr therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
May 1, 2025
·
6 min read
Press Releases
CDR-Life Presents Promising Preclinical Data for Novel T Cell Engager Programs at AACR Annual Meeting 2025
April 25, 2025
·
4 min read
CDR-Life Announces Initiation of CDR404 Phase 1 Trial for Treatment of Solid Tumors at ASCO
CDR-Life Inc. today announced the initiation of enrollment for the Phase 1 trial of CDR404, its lead program in development as a precision immunotherapy for solid tumors.
May 29, 2024
·
1 min read
CDR-Life Announces Pipeline Expansion of Highly Tumor-Targeted T Cell Engagers
CDR-Life Inc. today announced an expansion of its pipeline of novel T cell engagers (TCE) with the addition of CDR813 and CDR505.
June 25, 2024
·
2 min read
Press Releases
CDR-Life Announces Fifth Milestone Achievement with Boehringer Ingelheim in Geographic Atrophy
February 26, 2025
·
2 min read
CDR-Life to Present at 6th Annual Cell Engager Summit
CDR-Life Inc. today announced that Chief Medical Officer Swethajit Biswas, MD, FRCP, will co-lead a seminar at the 6th Annual Cell Engager Summit, occurring May 21-23 in Boston.
May 21, 2024
·
2 min read
Dassault Systèmes and CDR-Life Collaborate to Accelerate Scientific Innovation for Cancer Therapies
Dassault Systèmes announced it collaborated with CDR-Life, a Swiss biotherapeutics company, to accelerate CDR-Life’s development of next-generation highly tumor-selective immunotherapies using CDR-Life’s proprietary M-gager® platform.
March 12, 2024
·
4 min read
Press Releases
INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB
October 28, 2024
·
6 min read
Press Releases
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
October 21, 2024
·
11 min read
Press Releases
CDR-Life Announces Pipeline Progress of M-gager® Programs for Treatment of Solid Tumors
September 13, 2024
·
3 min read
1 of 26,907
Next
